Altana and Serono seeking mergers
November 30, 2005Sales and Marketing
Two of European pharma's mid-sized companies, Serono and Altana, have separately declared their openness to takeover talks, with Pfizer and …
Pfizer critical of generic plan for three million statin patients
November 30, 2005More than three million extra patients could be prescribed statins in England and Wales in response to new guidance – …
Pfizer’s new anti-smoking drug shows promise
November 29, 2005Sales and Marketing
Smokers taking a new Pfizer treatment are more likely to kick the habit compared to those using GlaxoSmithKline's Zyban, according …
Pharma unprepared for shift to secondary care
November 28, 2005Research and Development
Nine out of ten European pharmaceutical companies believe they need to make significant changes to their businesses as a result …
AstraZeneca fights generic Nexium bid
November 25, 2005Sales and Marketing
AstraZeneca has filed a lawsuit in the US courts to block the launch of a generic version of Nexium.The ulcer …
Which company has the industry’s best R&D pipeline?
November 25, 2005Sales and Marketing
Take part in Pharmafocus' industry poll on the leading product pipelinesThe pharma industry has experienced another turbulent year of change …
Chiron to make up shortfall in UK flu vaccine
November 25, 2005Manufacturing and Production
Chiron has agreed to help the UK government make up a shortfall in flu vaccine supplies by producing an extra …
PR as important as salesforces, say marketers
November 24, 2005Medical Communications
A new survey of the UK pharmaceutical industry has found PR is considered just as important to marketing efforts as …
FDA clears Tamiflu in children after safety scare
November 22, 2005Sales and Marketing
The FDA says there is no evidence that Tamiflu was linked to the death of 12 children taking the antiviral …
Amgen sues Roche over new anaemia treatment
November 22, 2005Sales and Marketing
Roche has released new phase II data for a highly promising new anaemia treatment – but Amgen are determined to …
New antibody could be COPD breakthrough, say companies
November 21, 2005Research and Development Argenta, COPD, Domantis
Two UK biotech companies say their innovative antibody drug could be a breakthrough in treating the chronic respiratory disease COPD.Chronic …
Asthma drug warning hits GlaxoSmithKline
November 21, 2005Sales and Marketing
Sales of GlaxoSmithKline's number one product asthma drug Advair could be hit by new safety warnings imposed by the US …
Oxford and GSK to collaborate on cancer research in India
November 18, 2005Research and Development
The University of Oxford and GlaxoSmithKline are to work together with researchers in India to set up the country's first …
Which company is pharma’s rising star?
November 17, 2005Sales and Marketing
Pharmaceutical executives are voting in their hundreds every week in a unique survey to find out which companies are the …
Patient demand brings Sativex to UK ahead of approval
November 17, 2005Sales and Marketing GW Pharmaceuticals, Sativex
The unlicensed cannabis-based medicine Sativex will be available in the UK to treat neuropathic pain on a named patient basis …
Haringey spawns new NHS collaboration for Pfizer
November 17, 2005Pfizer's high profile disease management project with Haringey Teaching PCT looks set to be declared a success – and has …
De Facto expands into med ed
November 17, 2005Medical Communications
PR firm De Facto has launched a medical education arm and signed up its first two clients for the new …
Stricter new UK industry code of practice launched
November 16, 2005Medical Communications, Sales and Marketing
The UK pharmaceutical industry is to adopt a new stricter code of conduct to help distance itself from allegations of …
Study results not IDEAL for Lipitor
November 16, 2005Research and Development, Sales and Marketing
A new study of Lipitor failed to show it was better than Merck's Zocor at preventing major coronary events.Results showing …
Complete prescribing power proposed for nurses and pharmacists
November 15, 2005Some nurses and pharmacists could soon be able to prescribe almost any drug available on the NHS under sweeping changes …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
